Amphastar Pharmaceuticals (FRA:29A) Accumulated other comprehensive income (loss) : €-8.1 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Amphastar Pharmaceuticals Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Amphastar Pharmaceuticals's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-8.1 Mil.

Amphastar Pharmaceuticals's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-7.9 Mil) to Dec. 2023 (€-7.8 Mil) but then declined from Dec. 2023 (€-7.8 Mil) to Mar. 2024 (€-8.1 Mil).

Amphastar Pharmaceuticals's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-6.0 Mil) to Dec. 2022 (€-8.1 Mil) but then increased from Dec. 2022 (€-8.1 Mil) to Dec. 2023 (€-7.8 Mil).

Amphastar Pharmaceuticals Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Amphastar Pharmaceuticals's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amphastar Pharmaceuticals Accumulated other comprehensive income (loss) Chart

Amphastar Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-4.22

-3.06

-5.99

-8.14

-7.77

Amphastar Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-7.72	-7.68	-7.88	-7.77	-8.07

Amphastar Pharmaceuticals Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Amphastar Pharmaceuticals Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Amphastar Pharmaceuticals (FRA:29A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amphastar Pharmaceuticals Inc (FRA:29A) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

AMPH:USA 29A:Germany

Address

11570 6th Street, Rancho Cucamonga, CA, USA, 91730

Website

http://www.amphastar.com

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Amphastar Pharmaceuticals (FRA:29A) Headlines

No Headlines